カテゴリー： LP Information, 世界, 医療/バイオ

子宮腔形子宮内器具のグローバル市場予測2023-2029

◆英語タイトル：Global Uterine Cavity Form Intra-Uterine Devices Market Growth 2023-2029
	◆商品コード：LP23DC02422 ◆発行会社（リサーチ会社）：LP Information ◆発行日：2023年11月 ◆ページ数：112 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など ◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥556,320	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥834,480	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,112,640	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LP Informationの最新刊調査レポート「子宮腔形子宮内器具のグローバル市場」は、過去の販売実績から2022年の世界の子宮腔形子宮内器具の総販売量を検討し、2023年から2029年の予測される子宮腔形子宮内器具の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の子宮腔形子宮内器具の市場規模を掲載し、XXX百万米ドル規模の世界の子宮腔形子宮内器具市場の詳細な分析を提供します。本インサイトレポートは、世界の子宮腔形子宮内器具業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の子宮腔形子宮内器具市場における各社の独自のポジションをより深く理解するために、子宮腔形子宮内器具製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の子宮腔形子宮内器具市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。子宮腔形子宮内器具の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。子宮腔形子宮内器具の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。子宮腔形子宮内器具のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

子宮腔形子宮内器具の世界主要メーカーとしては、Bayer AG、 Merck & Co., Inc.、 Pfizer Inc.、 Allergan、 Teva Pharmaceutical Industries Ltd.、 CooperSurgical、 Medicines360、 Agile Therapeutics、 Ferring Pharmaceuticals、 Gedeon Richter、 HLL Lifecare Limited、 Lupin Pharmaceuticals, Inc.、 Okamoto Industries, Inc.、 Pregna International Ltd.、 Synapse Medical Sdn Bhdなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の子宮腔形子宮内器具市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査では子宮腔形子宮内器具市場をセグメンテーションし、種類別 (銅製IUD、銀メッキIUD)、用途別 (病院、診療所)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：銅製IUD、銀メッキIUD

・用途別区分：病院、診療所

・地域別区分
南北アメリカ（米国、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の子宮腔形子宮内器具市場の10年間の市場状況・展望は？
・世界および地域別に見た子宮腔形子宮内器具市場成長の要因は何か？
・子宮腔形子宮内器具の市場機会はエンドマーケットの規模によってどのように変化するのか？
・子宮腔形子宮内器具のタイプ別、用途別の内訳は？
・新型コロナウイルスとロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：子宮腔形子宮内器具の年間販売量2018-2029、地域別現状・将来分析
・子宮腔形子宮内器具の種類別セグメント：銅製IUD、銀メッキIUD
・子宮腔形子宮内器具の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・子宮腔形子宮内器具の用途別セグメント：病院、診療所
・子宮腔形子宮内器具の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の子宮腔形子宮内器具市場
・企業別のグローバル子宮腔形子宮内器具市場データ：2018-2023年の年間販売量、市場シェア
・企業別の子宮腔形子宮内器具の年間売上：2018-2023年の売上、市場シェア
・企業別の子宮腔形子宮内器具販売価格
・主要企業の子宮腔形子宮内器具生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

子宮腔形子宮内器具の地域別レビュー
・地域別の子宮腔形子宮内器具市場規模2018-2023：年間販売量、売上
・主要国別の子宮腔形子宮内器具市場規模2018-2023：年間販売量、売上
・南北アメリカの子宮腔形子宮内器具販売の成長
・アジア太平洋の子宮腔形子宮内器具販売の成長
・ヨーロッパの子宮腔形子宮内器具販売の成長
・中東・アフリカの子宮腔形子宮内器具販売の成長

南北アメリカ市場
・南北アメリカの国別の子宮腔形子宮内器具販売量、売上（2018-2023）
・南北アメリカの子宮腔形子宮内器具の種類別販売量
・南北アメリカの子宮腔形子宮内器具の用途別販売量
・米国市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の子宮腔形子宮内器具販売量、売上（2018-2023）
・アジア太平洋の子宮腔形子宮内器具の種類別販売量
・アジア太平洋の子宮腔形子宮内器具の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の子宮腔形子宮内器具販売量、売上（2018-2023）
・ヨーロッパの子宮腔形子宮内器具の種類別販売量
・ヨーロッパの子宮腔形子宮内器具の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の子宮腔形子宮内器具販売量、売上（2018-2023）
・中東・アフリカの子宮腔形子宮内器具の種類別販売量
・中東・アフリカの子宮腔形子宮内器具の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・子宮腔形子宮内器具の製造コスト構造分析
・子宮腔形子宮内器具の製造プロセス分析
・子宮腔形子宮内器具の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・子宮腔形子宮内器具の主要なグローバル販売業者
・子宮腔形子宮内器具の主要なグローバル顧客

地域別の子宮腔形子宮内器具市場予測レビュー
・地域別の子宮腔形子宮内器具市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・子宮腔形子宮内器具の種類別市場規模予測
・子宮腔形子宮内器具の用途別市場規模予測

主要企業分析
Bayer AG、 Merck & Co., Inc.、 Pfizer Inc.、 Allergan、 Teva Pharmaceutical Industries Ltd.、 CooperSurgical、 Medicines360、 Agile Therapeutics、 Ferring Pharmaceuticals、 Gedeon Richter、 HLL Lifecare Limited、 Lupin Pharmaceuticals, Inc.、 Okamoto Industries, Inc.、 Pregna International Ltd.、 Synapse Medical Sdn Bhd
・企業情報
・子宮腔形子宮内器具製品
・子宮腔形子宮内器具販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Uterine Cavity Form Intra-Uterine Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Uterine Cavity Form Intra-Uterine Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Uterine Cavity Form Intra-Uterine Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Uterine Cavity Form Intra-Uterine Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Uterine Cavity Form Intra-Uterine Devices players cover Bayer AG, Merck & Co., Inc., Pfizer Inc., Allergan, Teva Pharmaceutical Industries Ltd., CooperSurgical, Medicines360, Agile Therapeutics and Ferring Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
An intrauterine device (IUD) is a contraceptive device inserted into the uterus to prevent pregnancy. It is a T-shaped device made of plastic and contains copper or hormones. The device is inserted into the uterus by medical professionals to play a role by preventing the fertilization of eggs or the implantation of zygote. The working principle of copper intrauterine devices is to release copper ions, which are toxic to sperm and hinder fertilization. Hormone type intrauterine devices work by releasing progesterone, thickening cervical mucus and preventing sperm from entering the egg. The design of a uterine intrauterine device conforms to the shape of the uterus and helps to reduce the risk of expulsion or displacement. This is a long-term contraceptive method that can prevent pregnancy within a few years, depending on the type of device used. Although intrauterine device (IUD) is a very effective contraceptive method, it is not suitable for everyone. Women with certain diseases, such as pelvic inflammatory disease or uterine abnormalities, may not be able to use intrauterine devices. It is important to consult medical professionals to determine whether an intrauterine device is the right contraceptive choice for you. Overall, intrauterine devices (IUDs) are a safe and effective contraceptive choice that can provide long-term contraceptive protection. Its high efficiency and low maintenance requirements make it a popular choice for many women.
LPI (LP Information)’ newest research report, the “Uterine Cavity Form Intra-Uterine Devices Industry Forecast” looks at past sales and reviews total world Uterine Cavity Form Intra-Uterine Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Uterine Cavity Form Intra-Uterine Devices sales for 2023 through 2029. With Uterine Cavity Form Intra-Uterine Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Uterine Cavity Form Intra-Uterine Devices industry.
This Insight Report provides a comprehensive analysis of the global Uterine Cavity Form Intra-Uterine Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Uterine Cavity Form Intra-Uterine Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Uterine Cavity Form Intra-Uterine Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Uterine Cavity Form Intra-Uterine Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Uterine Cavity Form Intra-Uterine Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Uterine Cavity Form Intra-Uterine Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Copper IUD
Silver Plated IUD
Segmentation by application
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Bayer AG
Merck & Co., Inc.
Pfizer Inc.
Allergan
Teva Pharmaceutical Industries Ltd.
CooperSurgical
Medicines360
Agile Therapeutics
Ferring Pharmaceuticals
Gedeon Richter
HLL Lifecare Limited
Lupin Pharmaceuticals, Inc.
Okamoto Industries, Inc.
Pregna International Ltd.
Synapse Medical Sdn Bhd
Key Questions Addressed in this Report
What is the 10-year outlook for the global Uterine Cavity Form Intra-Uterine Devices market?
What factors are driving Uterine Cavity Form Intra-Uterine Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Uterine Cavity Form Intra-Uterine Devices market opportunities vary by end market size?
How does Uterine Cavity Form Intra-Uterine Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Uterine Cavity Form Intra-Uterine Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Uterine Cavity Form Intra-Uterine Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Uterine Cavity Form Intra-Uterine Devices by Country/Region, 2018, 2022 & 2029
2.2 Uterine Cavity Form Intra-Uterine Devices Segment by Type
2.2.1 Copper IUD
2.2.2 Silver Plated IUD
2.3 Uterine Cavity Form Intra-Uterine Devices Sales by Type
2.3.1 Global Uterine Cavity Form Intra-Uterine Devices Sales Market Share by Type (2018-2023)
2.3.2 Global Uterine Cavity Form Intra-Uterine Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global Uterine Cavity Form Intra-Uterine Devices Sale Price by Type (2018-2023)
2.4 Uterine Cavity Form Intra-Uterine Devices Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Uterine Cavity Form Intra-Uterine Devices Sales by Application
2.5.1 Global Uterine Cavity Form Intra-Uterine Devices Sale Market Share by Application (2018-2023)
2.5.2 Global Uterine Cavity Form Intra-Uterine Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global Uterine Cavity Form Intra-Uterine Devices Sale Price by Application (2018-2023)
3 Global Uterine Cavity Form Intra-Uterine Devices by Company
3.1 Global Uterine Cavity Form Intra-Uterine Devices Breakdown Data by Company
3.1.1 Global Uterine Cavity Form Intra-Uterine Devices Annual Sales by Company (2018-2023)
3.1.2 Global Uterine Cavity Form Intra-Uterine Devices Sales Market Share by Company (2018-2023)
3.2 Global Uterine Cavity Form Intra-Uterine Devices Annual Revenue by Company (2018-2023)
3.2.1 Global Uterine Cavity Form Intra-Uterine Devices Revenue by Company (2018-2023)
3.2.2 Global Uterine Cavity Form Intra-Uterine Devices Revenue Market Share by Company (2018-2023)
3.3 Global Uterine Cavity Form Intra-Uterine Devices Sale Price by Company
3.4 Key Manufacturers Uterine Cavity Form Intra-Uterine Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Uterine Cavity Form Intra-Uterine Devices Product Location Distribution
3.4.2 Players Uterine Cavity Form Intra-Uterine Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Uterine Cavity Form Intra-Uterine Devices by Geographic Region
4.1 World Historic Uterine Cavity Form Intra-Uterine Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global Uterine Cavity Form Intra-Uterine Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Uterine Cavity Form Intra-Uterine Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Uterine Cavity Form Intra-Uterine Devices Market Size by Country/Region (2018-2023)
4.2.1 Global Uterine Cavity Form Intra-Uterine Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global Uterine Cavity Form Intra-Uterine Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Uterine Cavity Form Intra-Uterine Devices Sales Growth
4.4 APAC Uterine Cavity Form Intra-Uterine Devices Sales Growth
4.5 Europe Uterine Cavity Form Intra-Uterine Devices Sales Growth
4.6 Middle East & Africa Uterine Cavity Form Intra-Uterine Devices Sales Growth
5 Americas
5.1 Americas Uterine Cavity Form Intra-Uterine Devices Sales by Country
5.1.1 Americas Uterine Cavity Form Intra-Uterine Devices Sales by Country (2018-2023)
5.1.2 Americas Uterine Cavity Form Intra-Uterine Devices Revenue by Country (2018-2023)
5.2 Americas Uterine Cavity Form Intra-Uterine Devices Sales by Type
5.3 Americas Uterine Cavity Form Intra-Uterine Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Uterine Cavity Form Intra-Uterine Devices Sales by Region
6.1.1 APAC Uterine Cavity Form Intra-Uterine Devices Sales by Region (2018-2023)
6.1.2 APAC Uterine Cavity Form Intra-Uterine Devices Revenue by Region (2018-2023)
6.2 APAC Uterine Cavity Form Intra-Uterine Devices Sales by Type
6.3 APAC Uterine Cavity Form Intra-Uterine Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Uterine Cavity Form Intra-Uterine Devices by Country
7.1.1 Europe Uterine Cavity Form Intra-Uterine Devices Sales by Country (2018-2023)
7.1.2 Europe Uterine Cavity Form Intra-Uterine Devices Revenue by Country (2018-2023)
7.2 Europe Uterine Cavity Form Intra-Uterine Devices Sales by Type
7.3 Europe Uterine Cavity Form Intra-Uterine Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Uterine Cavity Form Intra-Uterine Devices by Country
8.1.1 Middle East & Africa Uterine Cavity Form Intra-Uterine Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa Uterine Cavity Form Intra-Uterine Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Uterine Cavity Form Intra-Uterine Devices Sales by Type
8.3 Middle East & Africa Uterine Cavity Form Intra-Uterine Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Uterine Cavity Form Intra-Uterine Devices
10.3 Manufacturing Process Analysis of Uterine Cavity Form Intra-Uterine Devices
10.4 Industry Chain Structure of Uterine Cavity Form Intra-Uterine Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Uterine Cavity Form Intra-Uterine Devices Distributors
11.3 Uterine Cavity Form Intra-Uterine Devices Customer
12 World Forecast Review for Uterine Cavity Form Intra-Uterine Devices by Geographic Region
12.1 Global Uterine Cavity Form Intra-Uterine Devices Market Size Forecast by Region
12.1.1 Global Uterine Cavity Form Intra-Uterine Devices Forecast by Region (2024-2029)
12.1.2 Global Uterine Cavity Form Intra-Uterine Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Uterine Cavity Form Intra-Uterine Devices Forecast by Type
12.7 Global Uterine Cavity Form Intra-Uterine Devices Forecast by Application
13 Key Players Analysis
13.1 Bayer AG
13.1.1 Bayer AG Company Information
13.1.2 Bayer AG Uterine Cavity Form Intra-Uterine Devices Product Portfolios and Specifications
13.1.3 Bayer AG Uterine Cavity Form Intra-Uterine Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bayer AG Main Business Overview
13.1.5 Bayer AG Latest Developments
13.2 Merck & Co., Inc.
13.2.1 Merck & Co., Inc. Company Information
13.2.2 Merck & Co., Inc. Uterine Cavity Form Intra-Uterine Devices Product Portfolios and Specifications
13.2.3 Merck & Co., Inc. Uterine Cavity Form Intra-Uterine Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck & Co., Inc. Main Business Overview
13.2.5 Merck & Co., Inc. Latest Developments
13.3 Pfizer Inc.
13.3.1 Pfizer Inc. Company Information
13.3.2 Pfizer Inc. Uterine Cavity Form Intra-Uterine Devices Product Portfolios and Specifications
13.3.3 Pfizer Inc. Uterine Cavity Form Intra-Uterine Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Inc. Main Business Overview
13.3.5 Pfizer Inc. Latest Developments
13.4 Allergan
13.4.1 Allergan Company Information
13.4.2 Allergan Uterine Cavity Form Intra-Uterine Devices Product Portfolios and Specifications
13.4.3 Allergan Uterine Cavity Form Intra-Uterine Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Allergan Main Business Overview
13.4.5 Allergan Latest Developments
13.5 Teva Pharmaceutical Industries Ltd.
13.5.1 Teva Pharmaceutical Industries Ltd. Company Information
13.5.2 Teva Pharmaceutical Industries Ltd. Uterine Cavity Form Intra-Uterine Devices Product Portfolios and Specifications
13.5.3 Teva Pharmaceutical Industries Ltd. Uterine Cavity Form Intra-Uterine Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
13.5.5 Teva Pharmaceutical Industries Ltd. Latest Developments
13.6 CooperSurgical
13.6.1 CooperSurgical Company Information
13.6.2 CooperSurgical Uterine Cavity Form Intra-Uterine Devices Product Portfolios and Specifications
13.6.3 CooperSurgical Uterine Cavity Form Intra-Uterine Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 CooperSurgical Main Business Overview
13.6.5 CooperSurgical Latest Developments
13.7 Medicines360
13.7.1 Medicines360 Company Information
13.7.2 Medicines360 Uterine Cavity Form Intra-Uterine Devices Product Portfolios and Specifications
13.7.3 Medicines360 Uterine Cavity Form Intra-Uterine Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Medicines360 Main Business Overview
13.7.5 Medicines360 Latest Developments
13.8 Agile Therapeutics
13.8.1 Agile Therapeutics Company Information
13.8.2 Agile Therapeutics Uterine Cavity Form Intra-Uterine Devices Product Portfolios and Specifications
13.8.3 Agile Therapeutics Uterine Cavity Form Intra-Uterine Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Agile Therapeutics Main Business Overview
13.8.5 Agile Therapeutics Latest Developments
13.9 Ferring Pharmaceuticals
13.9.1 Ferring Pharmaceuticals Company Information
13.9.2 Ferring Pharmaceuticals Uterine Cavity Form Intra-Uterine Devices Product Portfolios and Specifications
13.9.3 Ferring Pharmaceuticals Uterine Cavity Form Intra-Uterine Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Ferring Pharmaceuticals Main Business Overview
13.9.5 Ferring Pharmaceuticals Latest Developments
13.10 Gedeon Richter
13.10.1 Gedeon Richter Company Information
13.10.2 Gedeon Richter Uterine Cavity Form Intra-Uterine Devices Product Portfolios and Specifications
13.10.3 Gedeon Richter Uterine Cavity Form Intra-Uterine Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Gedeon Richter Main Business Overview
13.10.5 Gedeon Richter Latest Developments
13.11 HLL Lifecare Limited
13.11.1 HLL Lifecare Limited Company Information
13.11.2 HLL Lifecare Limited Uterine Cavity Form Intra-Uterine Devices Product Portfolios and Specifications
13.11.3 HLL Lifecare Limited Uterine Cavity Form Intra-Uterine Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 HLL Lifecare Limited Main Business Overview
13.11.5 HLL Lifecare Limited Latest Developments
13.12 Lupin Pharmaceuticals, Inc.
13.12.1 Lupin Pharmaceuticals, Inc. Company Information
13.12.2 Lupin Pharmaceuticals, Inc. Uterine Cavity Form Intra-Uterine Devices Product Portfolios and Specifications
13.12.3 Lupin Pharmaceuticals, Inc. Uterine Cavity Form Intra-Uterine Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Lupin Pharmaceuticals, Inc. Main Business Overview
13.12.5 Lupin Pharmaceuticals, Inc. Latest Developments
13.13 Okamoto Industries, Inc.
13.13.1 Okamoto Industries, Inc. Company Information
13.13.2 Okamoto Industries, Inc. Uterine Cavity Form Intra-Uterine Devices Product Portfolios and Specifications
13.13.3 Okamoto Industries, Inc. Uterine Cavity Form Intra-Uterine Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Okamoto Industries, Inc. Main Business Overview
13.13.5 Okamoto Industries, Inc. Latest Developments
13.14 Pregna International Ltd.
13.14.1 Pregna International Ltd. Company Information
13.14.2 Pregna International Ltd. Uterine Cavity Form Intra-Uterine Devices Product Portfolios and Specifications
13.14.3 Pregna International Ltd. Uterine Cavity Form Intra-Uterine Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Pregna International Ltd. Main Business Overview
13.14.5 Pregna International Ltd. Latest Developments
13.15 Synapse Medical Sdn Bhd
13.15.1 Synapse Medical Sdn Bhd Company Information
13.15.2 Synapse Medical Sdn Bhd Uterine Cavity Form Intra-Uterine Devices Product Portfolios and Specifications
13.15.3 Synapse Medical Sdn Bhd Uterine Cavity Form Intra-Uterine Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Synapse Medical Sdn Bhd Main Business Overview
13.15.5 Synapse Medical Sdn Bhd Latest Developments
14 Research Findings and Conclusion

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 子宮腔形子宮内器具のグローバル市場予測2023-2029(Global Uterine Cavity Form Intra-Uterine Devices Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

子宮腔形子宮内器具のグローバル市場予測2023-2029

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp